✦ LIBER ✦
Role of Anti-angiogenesis Agents in Treating NSCLC: Focus on Bevacizumab and VEGFR Tyrosine Kinase Inhibitors
✍ Scribed by Elwyn Cabebe; Heather Wakelee
- Book ID
- 107531984
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 203 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1527-2729
No coin nor oath required. For personal study only.